title: Chemokine CCR3 ligands-binding peptides derived from a random phage-epitope library.
abstract: Eosinophils are major effectors cells implicated in a number of chronic inflammatory diseases in humans, particularly bronchial asthma and allergic rhinitis. The human chemokine receptor C-C receptor 3 (hCCR3) provides a mechanism for the recruitment of eosinophils into tissue and thus has recently become an attractive biological target for therapeutic intervention. In order to develop peptides antagonists of hCCR3-hCCL11 (human eotaxin) interactions, a random bacteriophage hexapeptide library was used to map structural features of hCCR3 by determining the epitopes of neutralizing anti-hCCR3 mAb 7B11. This mAb t is selective for hCCR3 and exhibit potent antagonist activity in receptor binding and functional assays. After three rounds of biopanning, four mAb7B11-binding peptides were identified from a 6-mer linear peptide library. The phage bearing the peptides showed specific binding to immobilized mAb 7B11 with over 94% of phages bound being competitively inhibited by free synthetic peptides. In FACScan analysis all selected phage peptides were able to strongly inhibit the binding of mAb 7B11 to hCCR3-transfected preB-300-19 murine cells. Furthermore, synthetic peptides of the corresponding phage epitopes were effective in blocking the antibody-hCCR3 interactions and to inhibit the binding of hCCL11 to hCCR3 transfectants. Chemically synthesized peptides CKGERF, FERKGK, SSMKVK and RHVSSQ, effectively competed for (125)I-hCCL11 binding to hCCR3 with IC(50) ranging from 3.5 to 9.7μM. Calcium release and chemotaxis of hCCR3 transfectants or human eosinophils were inhibited by all peptides in a dose-dependent manner. Furthermore, they showed inhibitory effects on chemotaxis of human eosinophils induced by hCCL11, hCCL5, hCCL7, hCCL8, and hCCL24. Specificities of all selected peptides were assessed with hCXCR1, hCXCR2, hCXCR3, and hCCR5 receptors. Peptides CKGERF and FERKGK showed inhibitory effects on eosinophil chemotaxis in a murine model of mCCL11-induced peritoneal eosinophilia. The development of peptides inhibiting the interactions between hCCR3 and its chemokine ligands will facilitate the development of small peptides antagonists with the hope of ameliorating chronic inflammatory diseases in humans.
authors.affiliation: Laboratoire de Microbiologie et d'Epidémiologie Vétérinaire, Institut Pasteur de Tunis, Tunisia. mehdi.houimel@pasteur.rns.tn
authors.forename: Mehdi
authors.initials: M
authors.lastname: Houimel
authors.forename: Luca
authors.initials: L
authors.lastname: Mazzucchelli
mesh_terms: D000818:Animals; D002460:Cell Line; D002464:Cell Migration Inhibition / Q000187:drug effects / Q000276:immunology; D018925:Chemokines / Q000235:genetics / Q000276:immunology; D004195:Disease Models, Animal; D004802:Eosinophilia / Q000188:drug therapy / Q000235:genetics / Q000276:immunology / Q000473:pathology; D004804:Eosinophils / Q000276:immunology / Q000473:pathology; D000939:Epitopes / Q000235:genetics / Q000276:immunology* / Q000494:pharmacology; D006801:Humans; D051379:Mice; D019151:Peptide Library; D011485:Protein Binding / Q000235:genetics / Q000276:immunology; D054397:Receptors, CCR3 / Q000235:genetics / Q000276:immunology*
chemical_list: C515350:CCR3 protein, human; D018925:Chemokines; D000939:Epitopes; D019151:Peptide Library; D054397:Receptors, CCR3